AI-driven evolution of precision population cardiovascular health in cities.
No abstract available
COI Statement
Competing interests: A.A. is the head of the Novartis Foundation. M.A.W. declares no competing interests.
References:
World Heart Federation. World Heart Report 2023: Confronting the World’s Number One Killer (World Heart Federation, 2023).
Tanner, D. et al. Machine learning to evaluate the relationships between social determinants and diabetes prevalence in New York City. BMJ Public Health 2, e001394 (2024).
Zhang, J. et al. Artificial intelligence applied in cardiovascular disease: a bibliometric and visual analysis. Front. Cardiovasc. Med. 11, 1323918 (2024).
Hood, C. M., Gennuso, K. P., Swain, G. R. & Catlin, B. B. County health rankings: relationships between determinant factors and health outcomes. Am. J. Prev. Med. 50, 129–135 (2016).
Cai, Y. et al. Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review. BMC Med. 22, 56 (2024).